These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 9230743

  • 61. Comparing the efficacy of nebulizer recombinant human DNase and hypertonic saline as monotherapy and combined treatment in the treatment of persistent atelectasis in mechanically ventilated newborns.
    Altunhan H, Annagür A, Pekcan S, Ors R, Koç H.
    Pediatr Int; 2012 Feb; 54(1):131-6. PubMed ID: 22114907
    [Abstract] [Full Text] [Related]

  • 62. Is cystic fibrosis mucus abnormal?
    King M.
    Pediatr Res; 1981 Feb; 15(2):120-2. PubMed ID: 7254936
    [Abstract] [Full Text] [Related]

  • 63. Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.
    Ranasinha C, Assoufi B, Shak S, Christiansen D, Fuchs H, Empey D, Geddes D, Hodson M.
    Lancet; 1993 Jul 24; 342(8865):199-202. PubMed ID: 8100928
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Compaction assay: a rapid and simple in vitro method to assess the responsiveness of a biopolymer matrix to enzymatic modification.
    Daugherty AL, Patapoff TW, Clark RC, Sinicropi DV, Mrsny RJ.
    Biomaterials; 1995 May 24; 16(7):553-8. PubMed ID: 7492720
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I.
    Shah PL, Scott SF, Fuchs HJ, Geddes DM, Hodson ME.
    Thorax; 1995 Apr 24; 50(4):333-8. PubMed ID: 7785003
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Retrospective review of the effects of rhDNase in children with cystic fibrosis.
    Davies J, Trindade MT, Wallis C, Rosenthal M, Crawford O, Bush A.
    Pediatr Pulmonol; 1997 Apr 24; 23(4):243-8. PubMed ID: 9141109
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. The effect of erythromycin on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum.
    Shibuya Y, Wills PJ, Cole PJ.
    Respiration; 2001 Apr 24; 68(6):615-9. PubMed ID: 11786718
    [Abstract] [Full Text] [Related]

  • 76. Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?
    van der Giessen LJ, Gosselink R, Hop WC, Tiddens HA.
    Eur Respir J; 2007 Oct 24; 30(4):763-8. PubMed ID: 17596273
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial.
    Minasian C, Wallis C, Metcalfe C, Bush A.
    Thorax; 2010 Jan 24; 65(1):51-6. PubMed ID: 19996349
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. Hyaluronic acid improves "pleasantness" and tolerability of nebulized hypertonic saline in a cohort of patients with cystic fibrosis.
    Buonpensiero P, De Gregorio F, Sepe A, Di Pasqua A, Ferri P, Siano M, Terlizzi V, Raia V.
    Adv Ther; 2010 Nov 24; 27(11):870-8. PubMed ID: 20953746
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.